Coronary Artery Bypass Graft Market Study Highlights How Industry Demand Is Evolving

The coronary artery bypass graft market is set to experience significant expansion over the coming years, driven by continuous advancements in cardiac surgery and increasing demand for effective treatment options. This sector is witnessing rapid innovation and growing patient volumes, positioning it for robust growth through 2030 and beyond.

Market Size and Growth Forecast for the Coronary Artery Bypass Graft Market
The coronary artery bypass graft market is projected to reach a size of $21.08 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.2%. This strong growth is fueled by improvements in surgical techniques, rising numbers of cardiac surgeries, enhanced patient outcomes, the spread of specialized cardiac centers, and increasing healthcare spending worldwide. Key trends shaping the market include the rising adoption of minimally invasive CABG procedures, a greater use of off-pump surgeries, growing demand for multi-vessel bypass interventions, advanced post-operative recovery protocols, and the increasing implementation of hybrid cardiac treatment approaches.

The coronary artery bypass graft market size has grown strongly in recent years. It will grow from $13.61 billion in 2025 to $14.82 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to high coronary artery disease prevalence, limited alternative revascularization options, aging population growth, hospital-based surgical dominance, improved survival rates.

Download a free sample of the coronary artery bypass graft market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12673&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Primary Companies Leading the Coronary Artery Bypass Graft Market
Several prominent firms are influential players in the coronary artery bypass graft market, including CryoLife Inc., Johnson & Johnson Co, Abbott Laboratories, Medtronic plc, Stryker Corporation, Northwell Health, Boston Scientific Corporation, Penn Medicine, Geisinger Health System Co, Terumo Corporation, Edwards Lifesciences Corporation, Main Line Health Inc., Getinge AB, Teleflex Incorporated, W. L. Gore & Associates Inc., Guidant Group, LivaNova PLC, AtriCure Inc., Peter Surgical, Cardiva Medical Inc., Genesee Biomedical Inc., Dextera Surgical Inc., Cardica Inc., Maquet Holding B.V. & Co.KG, and Vitalitec International Medizintechnik GmbH.

Strategic Partnership Enhances CABG Outcomes in the UK
In February 2023, UK-based Kimal PLC, known for manufacturing vascular access devices and procedure packs, joined forces with Marizyme, Inc. to secure exclusive distribution rights for DuraGraft in the United Kingdom. This collaboration aims to combine Marizyme's cutting-edge vascular graft preservation technology with Kimal's extensive distribution capabilities to improve patient outcomes following coronary artery bypass graft surgeries. Marizyme Inc., headquartered in the US, is dedicated to developing novel medical device technologies that advance surgical care.

View the full coronary artery bypass graft market report:
https://www.thebusinessresearchcompany.com/report/coronary-artery-bypass-graft-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Bringing Innovation to the Coronary Artery Bypass Graft Market
Industry leaders are increasingly focusing on integrating surgical robotic systems to improve the precision and reduce the invasiveness of CABG procedures. These robotic platforms assist surgeons by providing enhanced visualization and control, which contributes to better patient outcomes and faster recovery times.

For example, in October 2023, SS Innovations International Inc., a US-based manufacturer of medical instruments, introduced its SSi Mantra surgical robotic system. This innovative technology is designed to deliver cost-effective robotic-assisted surgeries across several specialties, including cardiac operations. Key advantages include heightened surgical accuracy, minimized recovery periods due to less invasive techniques, and incorporation of machine learning for enhanced safety and operational efficiency.

Detailed Segmentation in the Coronary Artery Bypass Graft Market
The coronary artery bypass graft market can be categorized into several segments for a detailed understanding:

By Procedure Type:
- Single Coronary Artery Bypass Graft (CABG) Surgery
- Double Coronary Artery Bypass Graft (CABG) Surgery
- Triple Coronary Artery Bypass Graft (CABG) Surgery
- Quadruple Coronary Artery Bypass Graft (CABG) Surgery
- Other Procedures

By Method:
- Off-pump
- On-pump

By End-Use Sector:
- Hospitals
- Cardiology Clinics
- Research Institutes
- Other End-Users

Additional Subsegments Include:
- Single CABG: Left Internal Mammary Artery (LIMA) to Left Anterior Descending Artery (LAD)
- Double CABG: LIMA to LAD plus another artery
- Triple CABG: LIMA to LAD plus two other arteries
- Quadruple CABG: LIMA to LAD plus three other arteries
- Other Procedures: Off-pump CABG, Minimally Invasive CABG, Hybrid Procedures

This segmentation provides a comprehensive framework for understanding the scope and diversity of procedures and technologies in the coronary artery bypass graft market as it evolves.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.